EU Launches PFAS Reduction Project in Healthcare

As part of Horizon Europe (HORIZON), the Innovative Health Initiative (IHI) launched the "PFAS - Exposure, Emissions, and End-of-Life in the Healthcare Sector" project in January 2025. The initiative aims to reduce PFAS emissions and exposure while developing safe alternatives.

Key Objectives:

• Health Innovation & Competitiveness – Supports cross-sector innovation and EU healthcare leadership.
• Life Cycle Perspective – Identifies PFAS risks at all stages in healthcare.
• Risk Reduction – Develops safe disposal, reuse, and recycling methods.
• Alternative Solutions – Creates PFAS substitutes that meet regulatory and environmental standards.
• EU Leadership – Strengthens EU self-sufficiency in pharmaceuticals and medical R&D.
• Cooperation & Knowledge Transfer – Enhances collaboration and influences future PFAS policy.
• Planning Certainty – Provides clear regulatory guidance for medical manufacturers.

Target Groups: Medical and pharmaceutical companies, authorities, hospitals, and waste disposal firms.Application Deadlines:

• Phase 1: April 23, 2025
• Phase 2: October 14, 2025

More info: EU Funding & Tenders Portal.

31-03-2025

• Pharma GMP
• Food GMP
• Clinical Research
• Medical Device
• Environmental Health and Safety
• Healthcare
• Nutrition